NBIX
NEUROCRINE BIOSCIENCES INC
+2.48 (+1.66%)151.98USD186K成交股數15.4B市值22.3本益比(近四季)4.6股價營收比+39.5%營收年增(近四季)2026-10-28下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 959M+67% | 815M+30% | 795M+28% | 688M+16% | 573M+11% | 628M+26% | 622M+37% | 590M+40% | 515M | 499M | 453M | 420M |
| 營業成本 | 23.2M | 13.8M | 14.0M | 11.3M | 9.2M | 9.3M | 8.0M | 9.2M | 7.5M | 11.2M | 11.5M | 8.5M |
| 毛利 | 936M+66% | 801M+29% | 781M+27% | 676M+16% | 563M+11% | 618M+27% | 614M+39% | 581M+41% | 508M | 488M | 441M | 412M |
| 毛利率 | 97.6% | 98.3% | 98.2% | 98.4% | 98.4% | 98.5% | 98.7% | 98.4% | 98.5% | 97.8% | 97.5% | 98.0% |
| 研發費用 | 327M | 296M | 250M | 244M | 263M | 186M | 195M | 191M | 159M | 142M | 146M | 140M |
| 銷售管理費用 | 440M | 319M | 292M | 286M | 277M | 288M | 234M | 242M | 243M | 204M | 222M | 243M |
| 營業利益 | 152M+542% | 193M+36% | 239M+30% | 146M+0% | 23.6M-76% | 142M+1% | 184M+150% | 145M-227% | 99.3M | 141M | 73.6M | −114M |
| 營業利益率 | 15.8% | 23.7% | 30.1% | 21.2% | 4.1% | 22.6% | 29.5% | 24.6% | 19.3% | 28.3% | 16.3% | -27.2% |
| 稅後淨利 | 144M+1728% | 198M+92% | 210M+61% | 108M+65% | 7.9M-82% | 103M+24% | 130M+36% | 65.0M-185% | 43.4M | 83.1M | 95.5M | −76.6M |
| 淨利率 | 15.1% | 24.3% | 26.4% | 15.6% | 1.4% | 16.4% | 20.9% | 11.0% | 8.4% | 16.7% | 21.1% | -18.2% |
| 稀釋 EPS | 1.39+1638% | 1.91+91% | 2.04+65% | 1.06+68% | 0.08-81% | 1.00+22% | 1.24+31% | 0.63-180% | 0.42 | 0.82 | 0.95 | -0.79 |
| 稀釋股數 | 104M | 103M | 103M | 101M | 103M | 104M | 104M | 104M | 104M | 101M | 100M | 97.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 332M | 267M | 340M | 264M | 194M | 233M | 349M | 140M | 396M | 294M | 160M | 104M |
| 應收帳款 | 887M | 768M | 728M | 596M | 516M | 479M | 481M | 468M | 451M | 418M | 388M | 392M |
| 存貨 | 104M | 64.5M | 69.3M | 56.9M | 59.1M | 57.4M | 45.8M | 42.5M | 37.2M | 28.8M | 31.7M | 33.4M |
| 總資產 | 5.4B | 4.9B | 4.3B | 3.9B | 3.7B | 3.7B | 3.5B | 3.3B | 3.5B | 2.8B | 2.6B | 2.4B |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.7B | 1.5B | 1.3B | 1.2B | 1.2B | 1.1B | 816M | 796M | 1.1B | 846M | 760M | 675M |
| 股東權益 | 3.7B | 3.4B | 3.0B | 2.7B | 2.5B | 2.6B | 2.7B | 2.5B | 2.4B | 2.0B | 1.9B | 1.7B |
| 負債比 | 31.1% | 30.5% | 29.6% | 30.7% | 31.2% | 30.4% | 23.1% | 24.1% | 31.3% | 29.7% | 29.1% | 28.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 146M | – | – | 64.8M-50% | – | – | – | 130M | – | – | −125M |
| 資本支出 | – | 9.1M | – | – | 10.7M | – | – | – | 11.2M | – | – | 8.5M |
| 自由現金流 | – | 137M | – | – | 54.1M-55% | – | – | – | 119M | – | – | −134M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | 54.0M | – | – | 150M | – | – | – | 0.00 | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 16.8% | – | – | 9.4% | – | – | – | 23.1% | – | – | -31.8% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 2.9B
| Reportable | 2.9B | 100.0% | +21.4% |
|---|
產品／服務2025 年度 · 2.9B
| 產品 | 2.8B | 99.1% | +21.6% |
|---|---|---|---|
| Collaboration Revenue | 26.6M | 0.9% | +7.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.9B | +21.4% | 479M | 16.7% | 4.67 | 749M |
| FY2024 | 2.4B | +24.8% | 341M | 14.5% | 3.29 | 557M |
| FY2023 | 1.9B | +26.8% | 250M | 13.2% | 2.47 | 362M |
| FY2022 | 1.5B | +31.3% | 155M | 10.4% | 1.56 | 323M |
| FY2021 | 1.1B | +8.4% | 89.6M | 7.9% | 0.92 | 233M |
| FY2020 | 1.0B | +32.7% | 407M | 38.9% | 4.16 | 218M |
| FY2019 | 788M | +74.7% | 37.0M | 4.7% | 0.39 | 132M |
| FY2018 | 451M | – | 21.1M | 4.7% | 0.22 | 76.6M |